Polycomb Group Protein Bmi1 Is Required for Growth of RAF Driven Non-Small-Cell Lung Cancer
2009

Bmi1's Role in Lung Cancer Growth

Sample size: 8 publication 10 minutes Evidence: moderate

Author Information

Author(s): Becker Matthias, Korn Christian, Sienerth Arnold R., Voswinckel Robert, Luetkenhaus Katharina, Ceteci Fatih, Rapp Ulf R.

Primary Institution: Bayerisches Krebsforschungszentrum (MSZ), University of Wuerzburg, Wuerzburg, Germany

Hypothesis

Does the stem cell self-renewal factor Bmi1 affect tumor initiation and growth in RAF-driven non-small-cell lung cancer?

Conclusion

Bmi1 is essential for the growth of RAF-driven lung tumors but not for their initiation.

Supporting Evidence

  • Bmi1 ablation led to a significant decrease in tumor growth.
  • The number of tumors initiated was not significantly affected by Bmi1 deletion.
  • Cell death increased and cell cycle progression decreased in Bmi1−/−BXB11 mice.
  • Expression levels of p16INK4a and p19ARF were upregulated in the absence of Bmi1.

Takeaway

Bmi1 helps lung tumors grow bigger, but it doesn't start the tumors. It's like a helper that makes the tumors grow faster.

Methodology

The study used transgenic mouse models to evaluate the role of Bmi1 in tumor growth and initiation.

Potential Biases

Potential bias due to the limited genetic backgrounds of the mouse models used.

Limitations

The short lifespan of Bmi1 knockout mice limited the duration of tumor monitoring.

Participant Demographics

Mice from two transgenic founder lines (BXB11 and BXB23) were used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0004230

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication